Formation Bio is a biotechnology company that leverages artificial intelligence and technology to streamline the drug development process. The company aims to address the inefficiencies in clinical trials, which are a major bottleneck in bringing new treatments to patients. By integrating expertise from both the tech and pharmaceutical industries, Formation Bio seeks to accelerate the creation and approval of new drugs, making treatments more accessible and reducing healthcare costs.

Formation Bio

A platform for merging and training custom language models, offering cost-effective, secure, end-to-end solutions to build and deploy Small Language Models (SLMs).

Arcee.ai

Signant Health provides clinical trial technologies and services, generating clinical data.

Signant Health

S24 Global provides medical communications services that focus on innovative strategies for conveying complex scientific information, specifically for the pharmaceutical and biotechnology sectors.

S24 Global

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

We are excited to announce our collaboration with OpenAI and Sanofi to build fine-tuned and custom AI solutions to transform drug development. Since our inception, we have focused on building a pharma company differentiated by radical efficiency throughout drug development and clinical trials - and this collaboration helps us advance that vision. 
 
As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently.

You can read more about the collaboration here: https://lnkd.in/eYx9_QYg
#ai #drugdevelopment #clinicaltrials #pharma #biotech

Formation Bio will be attending PharmaSUG 2024! Our team members Helena Belloff Melanie Hullings Andrew Burd Emily Murphy Laura Fazio, MS will be presenting on May 20th and 21st - we hope to see you there! Details below. 

#software #datascience #pharma #biotech #conference #baltimore #statisticalprogramming #research #clinicaldevelopment #PharmaSUG2024

We have had an exciting Q1 at Formation Bio! We are thrilled to introduce our newest team members Amanda Hyler, Jamie C., Marianne Hawes, Joseph St.Amand, Gina DiGello, Benjamin Miles, Debra Wallace, and Jennifer Kang.

In honor of Women's Heritage Month, the Women's Employee Resource Group at Formation Bio - a tech-driven drug development company - is hosting a virtual event for young women interested in learning more about pursuing STEM fields on March 20th at 5 PM EST . We hope to inspire and empower young women by providing them with insights and guidance opportunities from successful women professionals at our organization. If you're interested in attending, please fill out this form so we can send you the Zoom links! #womensupportingwomen  #equality  #stem 

Sign up - https://lnkd.in/eVxmfe3D

Metric
Company Name	Formation Bio	Arcee.ai	Signant Health	S24 Global
Symbol
MSH ID	BIO:FORMATION	AI:ARCEE	COM:VIRTRIAL	UK:CO:S24GLOBAL
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Healthcare & Health Services	Commercial & Professional Services
Industry	Biotechnology	Artificial Intelligence and Machine Learning	Pharmaceuticals & Biotechnology	Healthcare & Health Services
Country	US		US	GB
Stage	Series D
Employee Count	167
Website	formation.bio	arcee.ai	virtrial.com	s24global.co.uk
LinkedIn	formationbio			s24group
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	7.58K
Web Traffic Growth	-0.56
Valuation
Raised Capital	372M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIO:FORMATION

Formation Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue